Normocalcemic primary hyperparathyroidism: Evidence for a generalized target-tissue resistance to parathyroid hormone

被引:138
作者
Maruani, G [1 ]
Hertig, A [1 ]
Paillard, M [1 ]
Houillier, P [1 ]
机构
[1] Univ Paris 06, Hop Europeen Georges Pomidou,Dept Physiol, Assistance Publ Hop Paris,INSERM,U356, Inst Federat Rech 58, F-75015 Paris, France
关键词
D O I
10.1210/jc.2002-021404
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Primary hyperparathyroidism (PHPT) is usually characterized by fasting hypercalcemia associated with inappropriately high PTH concentration. Nevertheless, cases of proven PHPT have been reported in normocalcemic patients. The purpose of the study was to investigate the mechanism(s) of persistent normocalcemia in PHPT. One hundred seventy-eight patients with PHPT were studied after exclusion of any evident cause of masked hypercalcemia. Patients were separated into normocalcemic (n = 34) and hypercalcemic (n = 144) subgroups on the basis of their fasting serum ionized calcium value. Patients with normocalcemic PHPT had, on average, a milder excess in PTH secretion assessed by a lower serum PTH concentration. Because of a clear overlap in PTH values between the two groups, normocalcemic and hypercalcemic patients were matched on the basis of serum PTH concentration, age, and sex. Patients with normocalcemic PHPT had lower fasting urine calcium excretion and renal tubular calcium reabsorption. In addition, normocalcemic patients differed from hypercalcemic patients by lower values of markers of bone turnover and plasma 1,25 dihydroxyvitamin D and higher values of renal phosphate threshold. In conclusion, a significant proportion of patients with PHPT are truly normocalcemic, and in addition to a milder increase in PTH secretion, the normocalcemic patients appear to display resistance to PTH action on bone and kidney.
引用
收藏
页码:4641 / 4648
页数:8
相关论文
共 37 条
[1]   ASSESSMENT OF PHOSPHATE REABSORPTION [J].
BIJVOET, OLM ;
MORGAN, DB ;
FOURMAN, P .
CLINICA CHIMICA ACTA, 1969, 26 (01) :15-+
[2]  
Bilezikian John P., 1994, P457
[3]   PATHOGENESIS OF SO-CALLED IDIOPATHIC HYPERCALCIURIA [J].
BORDIER, P ;
RYCKEWART, A ;
GUERIS, J ;
RASMUSSEN, H .
AMERICAN JOURNAL OF MEDICINE, 1977, 63 (03) :398-409
[4]   NEPHROGENOUS CYCLIC ADENOSINE-MONOPHOSPHATE AS A PARATHYROID FUNCTION TEST [J].
BROADUS, AE ;
MAHAFFEY, JE ;
BARTTER, FC ;
NEER, RM .
JOURNAL OF CLINICAL INVESTIGATION, 1977, 60 (04) :771-783
[5]   PRIMARY HYPERPARATHYROIDISM WITH INTERMITTENT HYPERCALCEMIA - SERIAL OBSERVATIONS AND SIMPLE DIAGNOSIS BY MEANS OF AN ORAL CALCIUM TOLERANCE-TEST [J].
BROADUS, AE ;
HORST, RL ;
LITTLEDIKE, ET ;
MAHAFFEY, JE ;
RASMUSSEN, H .
CLINICAL ENDOCRINOLOGY, 1980, 12 (03) :225-235
[6]   Oral calcium tolerance test in the early diagnosis of primary hyperparathyroidism and multiple endocrine neoplasia type 1 in patients with the Zollinger-Ellison syndrome [J].
Cadiot, G ;
Houillier, P ;
Allouch, A ;
Paillard, M ;
Mignon, M .
GUT, 1996, 39 (02) :273-278
[7]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[8]   ESTROGEN PROTECTION AGAINST BONE RESORBING EFFECTS OF PARATHYROID-HORMONE INFUSION - ASSESSMENT BY USE OF BIOCHEMICAL MARKERS [J].
COSMAN, F ;
SHEN, V ;
XIE, F ;
SEIBEL, M ;
RATCLIFFE, A ;
LINDSAY, R .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (05) :337-343
[9]  
DENT CE, 1975, LANCET, V1, P1161
[10]  
FORSTER J, 1988, SURGERY, V104, P1137